Stimuloton (sertraline hydrochloride) 50 mg x 10 tablets, 50 mg x 30 tablets, 100 mg x 28 tablets

• Treatment of major depressive disorder
• Treatment of obsessive-compulsive disorders (OCD)
• Treatment of panic disorder with or without agoraphobia
• Treatment of posttraumatic stress disorder; long-term use to prevent relapse and sustain symptom improvement
• Treatment of premenstrual dysphoric disorder (PMDD)
• Unlabeled use: generalized social phobia

• Contraindicated with hypersensitivity to sertraline; pregnancy.
• Use cautiously with impaired hepatic or renal function, lactation.

• CNS: Headache, nervousness, drowsiness, anxiety, tremor, dizziness, insomnia, light-headedness, agitation, sedation, abnormal gait, convulsions, vision changes, fatigue
• CV: Hot flashes, palpitations, chest pain
• Dermatologic: Sweating, rash, pruritus, acne, contact dermatitis
• GI: Nausea, vomiting, diarrhea, dry mouth, anorexia, dyspepsia, constipation, taste changes, flatulence, gastroenteritis, dysphagia, gingivitis
• GU: Painful menstruation, sexual dysfunction, frequency, cystitis, impotence, urgency, vaginitis
• Respiratory: Upper respiratory infections, pharyngitis, cough, dyspnea, bronchitis, rhinitis
• Other: Hot flashes, fever, back pain, thirst

Drug-drug

• Serious, sometimes fatal, reactions with MAO inhibitors; allow at least 14 days to elapse between MAOI and sertraline use
• Increased serum levels of sertraline with cimetidine
• Possible risk of increased QTc interval if combined with pimozide; do not use together
  - Drug-food
• Increased rate of absorption with food

DO NOT SHARE THIS MEDICINE with others. DO NOT USE THIS MEDICINE for other health conditions. KEEP THIS PRODUCT, as well as syringes and needles, if needed during treatment, out of the reach of children. Do not reuse needles, syringes, or other materials.